Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the Citi's 2018 Global Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the Citi's 2018 Global Healthcare Conference on Wednesday, December 5th, at the Lotte New York...

Key Takeaway: NEW BRUNSWICK, N.J. , Nov. 12, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Citi's 2018 Global Healthcare Conference on Wednesday, December 5 th , at the Lotte New York Palace Hotel in New York City. Joseph J. Wolk , Executive Vice President and Chi

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Nov. 12, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Citi's 2018 Global Healthcare Conference on Wednesday, December 5 th , at the Lotte New York Palace Hotel in New York City. Joseph J. Wolk , Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 10:15 a.m. (Eastern).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Last updated: Nov 12, 2018